Pivotal Response Treatment for Infants At-Risk for Autism Spectrum Disorder
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01691066|
Recruitment Status : Unknown
Verified July 2015 by Yale University.
Recruitment status was: Active, not recruiting
First Posted : September 24, 2012
Last Update Posted : July 2, 2015
|Condition or disease||Intervention/treatment||Phase|
|Autism Spectrum Disorders||Behavioral: Infant Toddler Years PRT||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||30 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Pivotal Response Treatment for Infants At-Risk for Autism Spectrum Disorder|
|Study Start Date :||September 2012|
|Actual Primary Completion Date :||September 2014|
|Estimated Study Completion Date :||September 2015|
Experimental: Infant Toddler Years PRT
Infant Toddler PRT in an evidence-based, manualized treatment for children with autism spectrum disorder that involves specific motivational behavioral procedures adapted to be developmentally appropriate for 12-15 month old infants who present with developmental delays.
Behavioral: Infant Toddler Years PRT
Other Name: Pivotal Response Treatment
No Intervention: Community Treatment
Community Treatment includes the treatments offered by early intervention services (e.g., speech-language therapy, special education instruction).
- Feasibility of a novel behavioral treatment [ Time Frame: 24 months ]
Assessment of Outcome:
Attendance. Attendance to parent education sessions will be recorded by the therapist.
Parent utilization. To assess the acceptability of the PRT approach, parents will be asked to keep a weekly log of procedure use, including overall estimated duration and choice of activities.
- Acceptability of a novel behavioral treatment [ Time Frame: 24 months ]
Assessment of Outcome:
Parent satisfaction. At post-treatment, parents will be asked to complete a Likert-scale and short response questionnaire rating their satisfaction with various aspects of the program
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01691066
|United States, Connecticut|
|Yale Child Study Center|
|New Haven, Connecticut, United States, 06510|
|Principal Investigator:||Katarzyna Chawarska, PhD||Yale University|